Brief: BioMerieux Eyes 2026 Sales Growth Of 5-7% LFL

Biomerieux SA

27/02/2026 05:54

Feb 27 (Reuters) - BioMerieux SA BIOX.PA:

2025 SALES: +6% ORGANIC GROWTH, CEBIT1 +16% ORGANIC INCREASE

DIVIDEND OF €0.98 PER SHARE, REPRESENTING A 9% INCREASE VERSUS LAST YEAR

2026 OUTLOOK IN LINE WITH GO•28 STRATEGIC PLAN AMBITIONS

OUTLOOK 2026: SALES ARE EXPECTED TO GROW BETWEEN +5% AND +7% ON A LIKE-FOR-LIKE BASIS

2025 NET INCOME, GROUP SHARE EUR 398 MILLION

IN 2025, CONTRIBUTIVE OPERATING INCOME BEFORE NON-RECURRING ITEMS (CEBIT) REACHED €728 MILLION,  UP 16% AT CONSTANT EXCHANGE RATES AND SCOPE

OUTLOOK 2026: CONTRIBUTIVE OPERATING INCOME BEFORE NON-RECURRING ITEMS IS EXPECTED TO GROW BY AT LEAST +10%

FY NET SALES EUR 4.07 BILLION

Source text: here

Further company coverage: BIOX.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))